Literature DB >> 6265935

Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity.

Z Farfel, V M Brothers, A S Brickman, F Conte, R Neer, H R Bourne.   

Abstract

Pseudohypoparathyroidism, type I (PHP-I) is an inherited disorder of primary resistance to multiple hormones that work by stimulating adenylate cyclase. In an attempt to clarify the mode of inheritance of PHP-I, we measured the activity of the N protein, a receptor-cyclase coupling component, in erythrocyte membranes. Erythrocyte N-protein activity was reduced by approximately 50% in erythrocytes of 15 PHP-I patients and was normal in 19 of their clinically normal first degree relatives. Reduced N-protein activity and the PHP-I phenotype in these families exhibited both dominant and recessive patterns of inheritance. This suggests that at least two distinct genetic loci are involved in inheritance of N-protein deficiency. In two additional families, dominant inheritance of the PHP-I phenotype was associated with normal activities of erythrocyte N protein. Thus, it appears that mutation of at least one additional genetic locus, not involving the N protein, can produce PHP-I.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265935      PMCID: PMC319507          DOI: 10.1073/pnas.78.5.3098

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Albright's hereditary osteodystrophy comprising pseudohypoparathyroidism and pseudo-pseudohypoparathyroidism. With a report of two cases representing the complete syndrome occurring in successive generations.

Authors:  J B MANN; S ALTERMAN; A G HILLS
Journal:  Ann Intern Med       Date:  1962-02       Impact factor: 25.391

2.  Partial gonadotrophin-resistance in pseudohypoparathyroidism.

Authors:  J I Wolfsdorf; R L Rosenfield; V S Fang; R Kobayashi; A K Razdan; M H Kim
Journal:  Acta Endocrinol (Copenh)       Date:  1978-06

Review 3.  Pseudohypoparathyroidism.

Authors:  E A Werder
Journal:  Ergeb Inn Med Kinderheilkd       Date:  1979

4.  The role of hormone receptors and GTP-regulatory proteins in membrane transduction.

Authors:  M Rodbell
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

5.  Metabolic interference and the + - heterozygote. a hypothetical form of simple inheritance which is neither dominant nor recessive.

Authors:  W G Johnson
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

6.  Reconstitution of catecholamine-sensitive adenylate cyclase. Reconstitution of the uncoupled variant of the S40 lymphoma cell.

Authors:  P C Sternweis; A G Gilman
Journal:  J Biol Chem       Date:  1979-05-10       Impact factor: 5.157

7.  Adenylate cyclase permanently uncoupled from hormone receptors in a novel variant of S49 mouse lymphoma cells.

Authors:  T Haga; E M Ross; H J Anderson; A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

8.  Prolactin deficiency in pseudohypoparathyroidism.

Authors:  H E Carlson; A S Brickman; G F Bottazzo
Journal:  N Engl J Med       Date:  1977-01-20       Impact factor: 91.245

9.  Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone.

Authors:  L R Chase; G L Melson; G D Aurbach
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

10.  Defect of receptor-cyclase coupling protein in psudohypoparathyroidism.

Authors:  Z Farfel; A S Brickman; H R Kaslow; V M Brothers; H R Bourne
Journal:  N Engl J Med       Date:  1980-07-31       Impact factor: 91.245

View more
  14 in total

Review 1.  Clinical spectrum and pathogenesis of pseudohypoparathyroidism.

Authors:  M A Levine
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Genetic deficiency of the alpha subunit of the guanine nucleotide-binding protein Gs as the molecular basis for Albright hereditary osteodystrophy.

Authors:  M A Levine; T G Ahn; S F Klupt; K D Kaufman; P M Smallwood; H R Bourne; K A Sullivan; C Van Dop
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

Review 3.  Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.

Authors:  Giovanna Mantovani; Anna Spada; Francesca Marta Elli
Journal:  Nat Rev Endocrinol       Date:  2016-04-22       Impact factor: 43.330

4.  Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsα-receptor interaction.

Authors:  Susanne Thiele; Luisa de Sanctis; Ralf Werner; Joachim Grötzinger; Cumhur Aydin; Harald Jüppner; Murat Bastepe; Olaf Hiort
Journal:  Hum Mutat       Date:  2011-04-12       Impact factor: 4.878

5.  Olfactory GTP-binding protein: signal-transducing polypeptide of vertebrate chemosensory neurons.

Authors:  U Pace; D Lancet
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 6.  Heterotrimeric G proteins in the control of parathyroid hormone actions.

Authors:  Murat Bastepe; Serap Turan; Qing He
Journal:  J Mol Endocrinol       Date:  2017-05       Impact factor: 5.098

Review 7.  Imprinting in Albright's hereditary osteodystrophy.

Authors:  S J Davies; H E Hughes
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

8.  Conditional activation defect of a human Gsalpha mutant.

Authors:  T Iiri; Z Farfel; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

9.  Pseudohypoparathyroidism type Ia: two new heterozygous frameshift mutations in exons 5 and 10 of the Gs alpha gene.

Authors:  H Shapira; M Mouallem; M S Shapiro; Y Weisman; Z Farfel
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

10.  Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart.

Authors:  A M Feldman; A E Cates; W B Veazey; R E Hershberger; M R Bristow; K L Baughman; W A Baumgartner; C Van Dop
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.